ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2026
Heterogeneous neuroimaging findings in obsessive-compulsive disorder converge to a common brain network using coordinate network mapping.
Article in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Neuroimaging studies in obsessive-compulsive disorder (OCD) have yielded heterogeneous findings, limiting efforts to localize OCD to specific brain regions or networks. This study applied coordinate network mapping (CNM) to test whether these distributed abnormalities converge onto a common brain network and to explore the biological substrates of this network through associations with neurotransmitter systems. We systematically reviewed and extracted coordinates of significant clusters from 66 Gy matter volume (GMV) and resting-state activity studies involving 3123 patients with OCD and 3116 healthy controls. Using CNM and functional connectome data from 1000 healthy individuals, we identified brain networks functionally connected to these abnormalities. Spatial correlations were examined between identified networks and 19 types of neurotransmitter maps acquired from over 1000 healthy subjects. The GMV and resting-state activity findings in OCD both converged to a common, functionally connected brain network involving the striatum, thalamus, cingulate, supplementary motor area, insula, and inferior frontal and superior temporal gyri. The identified networks derived from the two neuroimaging modalities were significantly correlated with the N-Methyl-D-Aspartate (NMDA) receptor distribution (r = 0.551 and r = 0.541, respectively; p < 0.001). Findings were robust across different methodological parameters and demonstrated good test-retest reliability. This study identifies a robust and reproducible brain network underlying the heterogeneous neuroimaging abnormalities in OCD, helping to interpret previous inconsistencies. Furthermore, the alignment of this network with the cortico-striato-thalamo-cortical circuitry and NMDA receptor distribution underscores its biological and clinical relevance, thereby illuminating potential targets for future neuromodulation and pharmacological interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.